Confirmation of the Y215H mutation in the β 2 -octopamine receptor in Varroa destructor is associated with contemporary cases of amitraz resistance in the United States.
Autor: | Rinkevich FD; USDA-ARS Honey Bee Breeding, Genetics, and Physiology Laboratory, Baton Rouge, LA, USA., Moreno-Martí S; Institute BIOTECMED, Universitat de València, Burjassot, Spain., Hernández-Rodríguez CS; Institute BIOTECMED, Universitat de València, Burjassot, Spain., González-Cabrera J; Institute BIOTECMED, Universitat de València, Burjassot, Spain. |
---|---|
Jazyk: | angličtina |
Zdroj: | Pest management science [Pest Manag Sci] 2023 Aug; Vol. 79 (8), pp. 2840-2845. Date of Electronic Publication: 2023 Apr 11. |
DOI: | 10.1002/ps.7461 |
Abstrakt: | Background: The parasitic mite, Varroa destructor (Anderson and Trueman), is a leading cause of honey bee colony losses around the world. Application of miticides such as amitraz are often the primary method of Varroa control in commercial beekeeping operations in the United States. It is likely that excessive and exclusive amitraz application has led to the development of amitraz resistance in Varroa. A mutation of tyrosine at amino acid position 215 to histidine (Y215H) in the β Results: There was a strong association of susceptible and resistant phenotypes with the corresponding susceptible and resistant genotypes respectively, and vice versa. The resistance bioassay may understate resistance levels because of the influence of environmental conditions on the outcome of the test, whereby Varroa with an amitraz-resistant genotype may appear with a susceptible phenotype. Conclusion: Confirmation of the Y215H mutation in the β (© 2023 Society of Chemical Industry. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.) |
Databáze: | MEDLINE |
Externí odkaz: |